737 results
·
16ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE-PERLANE-RESTYLANE-L/PERLANE-L AND RESTYLANE-SILK INJECTABLE GELS
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·HYLAFORM FAMILY DERMAL FILLERS (HYLAFORM, HYLAFORM PLUS AND CAPTIQUE INJECTABLE GEL)
Implantable Pulse Generator, Pacemaker (Non-Crt)
FDA Pre-Market Approval
FDA Class 3
·EASYTRAK 3 IS-1 LEADS
Permanent Defibrillator Electrodes
FDA Pre-Market Approval
FDA Class 3
·ACUITY STEERABLE IS-1 LEADS
Biologic Material, Dental
FDA Pre-Market Approval
FDA Class 3
·Straumann® Emdogain®
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·URO VYSION BLADDER CANCER KIT ASSAY
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·Juvéderm Injectable Gel Implants (Voluma XC, Vollure XC, Volbella XC, Volux XC, Skinvive)
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·Restylane, Perlane, Restylane-L, Restylane Lyft with Lidocane and Restylane Silk Injectable Gels
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·Juvederm Injectable Gel Implants, Juvederm Voluma XC, Juvederm Vollure XC, Juvederm Volbella XC
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·PATHVYSION HER-2 DNA PROBE KIT
Filler, Bone Void, Synthetic Peptide
FDA Pre-Market Approval
FDA Class 3
·AUGMENT Bone Graft and AUGMENT Injectable
Ablation System, High Intensity Focused Ultrasound (Hifu), Mr-Guided
FDA Pre-Market Approval
FDA Class 3
·Exablate 2100/2100 VI System
Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled
FDA classification
FDA Class 3
·Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·GELSYN-3
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·IMMULITE / IMMULITE 1000 AND IMMULITE 2000 FREE PSA ASSAYS
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE